Dupilumab (Dupixent) for eczema and the eyes: red, sticky or itchy eyes in a child or teenager, and when to tell the dermatologist
A child or teenager started dupilumab for eczema and the eyes are red, itchy or sticky. Here is what that usually is, why to keep treating the eczema and tell the dermatologist, and the signs that need an eye doctor the same day.
See an eye doctor the same day if your child…- Conjunctivitis and blepharitis (red eyes and inflamed eyelid edges) are known side effects of dupilumab, listed in its prescribing information, and the studies in children disagree on how often they happen.
- Parents usually see red, itchy, watering or sticky eyes, sometimes with pink or crusty eyelid edges, and it can be hard to tell from the eczema or an allergy without a doctor looking.
- Do not stop the injection yourselves. Tell the dermatologist or prescriber early, because the decision to continue, pause or stop belongs to them.
- Most cases are managed with drops or lid treatment that the prescriber or eye doctor chooses, and under 7 years a British consensus says to refer to an eye doctor.
- Pain, sensitivity to light, blurred vision or a white spot on the clear front of the eye needs an eye doctor the same day.
A child or teenager has moderate-to-severe eczema and has started dupilumab, a biologic injection for eczema sold as Dupixent. Then the eyes turn red, itchy or sticky, or the eyelids go pink and sore. Parents ask whether the injection is to blame, whether it must stop, and who to see. This page answers those questions and says what to tell each doctor.
One rule comes first. The injection is prescribed and supervised by the dermatologist or paediatrician who started it. Whether to continue, pause or stop is their decision, made with the eye doctor if needed. Nothing here is a reason to skip a dose at home. What a family can do is notice, write it down and tell the prescriber early.
Can dupilumab cause red, itchy or sticky eyes in a child?
Yes. Conjunctivitis (inflammation of the thin clear layer over the white of the eye) and blepharitis (inflamed, red eyelid edges) are known side effects. The US prescribing information lists conjunctivitis, blepharitis, keratitis, itchy eyes and dry eye among the common reactions in people treated for eczema, and says conjunctivitis and keratitis occurred more often than with a dummy injection.
It is not rare, and the studies disagree on how common. A Dutch registry followed 104 children and teenagers aged 3 to 17 and found that 34.6% developed what is called dupilumab-associated ocular surface disease, with 3.8% stopping the injection because of it.
A children's hospital in Singapore reviewed 216 patients and found 7.4% had an eye problem diagnosed by an ophthalmologist, none needing to stop. Differences in how the eyes were checked probably explain part of the gap. The Dutch study found it was not age-dependent and not linked to earlier allergic conjunctivitis.
For a parent the practical point is simple. Redness or itch after starting the injection is a known possibility, not a sign that something was done wrong, and it is worth reporting.
What do parents see, and is it the eczema or the injection?
Usually red, itchy, watery or sticky eyes, sometimes with pink, swollen or crusty eyelid edges. In the Dutch registry the most common symptoms were itching (75%), redness (72%) and tearing (58%). It is often hard to say from the doorway whether this is the injection, the eczema or an allergy, and that is exactly why the doctors look.
Eczema near the eyes can itself make the lids red, dry and itchy, and our page on eyelid eczema in children describes it. Allergy inside the eye gives itch and watering, covered in allergic eyes in children. An infection such as pink eye has its own pattern. The Singapore review noted that every child with an eye problem on dupilumab also had eczema of the eyelids or of the head and neck, so the skin around the eyes is worth mentioning.
Young children cannot say what feels wrong. The Dutch authors point out that reporting eye symptoms is hard for little ones and may delay the diagnosis. A child who rubs the eyes a lot, squints at light or blinks more since starting the injection is telling you something.
Should we stop the injection if the eyes are red or itchy?
No, not on your own. Tell the prescriber and keep to the treatment plan until they say otherwise. A British consensus guideline from dermatologists and eye doctors says the risk of eye side effects should not put clinicians or patients off using dupilumab, and that talk of withdrawing it should be prompted only by a big effect on quality of life, a threat to sight or other complications.
The prescribing information asks families to report new or worsening eye symptoms promptly. It says the prescriber may consider stopping if symptoms persist or worsen, and may ask for an eye examination. So the decision exists, but it belongs to the doctors. Stopping alone can let the eczema flare, and a flare around the eyes brings its own itching and rubbing.
The same consensus says starting dupilumab should not usually be delayed because of an eye condition, apart from a new acute problem such as an infection or a serious history such as a corneal transplant. If your child has an existing eye condition, tell the dermatologist before the first dose.
How is it treated, and who decides on drops?
Most cases are handled with the prescriber, sometimes with an eye doctor, and the drops or ointment are chosen by them. In the Dutch registry the first step was lubricating drops, antihistamine drops or an ointment for the outer eyelids, and only persistent symptoms needed anti-inflammatory eye treatment. That is how it went in one centre, not a plan to copy. Which drop suits which child, how often and for how long is a medical decision, and some eye drops need an eye doctor to supervise them.
Age changes the route. The British consensus says that for children under 7 the eye problem should be referred to an ophthalmologist whatever its severity, because eye complications at that age may affect visual development. For children of 7 and over, a dermatologist may try treatment first and send on those who are severe or not improving. In the Singapore review, the median time to settle was 14 weeks, and none had to stop the injection for good.
Eyelid care is often part of it, such as keeping the lid edges clean as the doctor shows. Please do not buy or reuse leftover drops. Our page on eye drops in the house explains safe storage, and nothing in it is a recommendation for a particular product.
When does a red eye on dupilumab need an eye doctor today?
When there is pain, sensitivity to light, blurred or reduced vision, or a white or grey spot on the clear front of the eye. These can mean the cornea, the clear window at the front, is inflamed (keratitis), and the cornea needs a look the same day. The prescribing information says keratitis occurred more often in people treated for eczema, and advises prompt eye examination when signs suggest it.
It also says that, after the medicine was on the market, some people reported visual impairment, including blindness, linked to conjunctivitis, keratitis or blepharitis. These reports are uncommon, but they are the reason the advice is to report early and not to wait. A red eye that is only itchy and slightly sticky can usually wait for the prescriber's appointment. A painful eye, a child who will not open the eyes to light, or a change in sight cannot.
Go to an eye doctor or an emergency department the same day, and tell them about the injection. Do not wait to see whether the eye settles overnight. Take the child out of contact lenses if they wear them.
What should we tell the dermatologist and the eye doctor?
Tell each doctor the other exists. Tell the dermatologist the day the eyes changed, what you saw, whether the child rubs the eyes, and whether the eyelids are sore or crusted. Tell the eye doctor the name of the injection (dupilumab), the date of the first dose and the latest one, any drops or ointments already used, and the eczema history.
A short note on the phone, with dates, helps both of them. Take a clear photo of the eyes and eyelids when they are at their worst, since they often look better by the appointment. A stye or a stuck eyelash can also happen on top of all this, and is easy to mix up.
Ask the prescriber one more thing: which symptoms they want a call about the same day. Then you do not have to guess at midnight. The checks, the drops and the decision on the injection stay with them.
- Has a painful eye, or cannot bear light and keeps the eye shut.
- Says the sight is blurred, or seems to see less than before.
- Has a white or grey spot on the clear front of the eye, or a red eye that is getting worse. Tell the prescriber too.
Common questions
Can dupilumab cause eye problems in a child?
Are Dupixent eye problems common in children?
Should my child stop dupilumab if the eyes are red and itchy?
What do red, itchy eyes on dupilumab look like?
Which eye drops should I use for my child on dupilumab?
When should a child on dupilumab see an eye doctor urgently?
Does a child under 7 on dupilumab need an eye doctor?
What should I tell the dermatologist and the eye doctor?
- US FDA / DailyMed · Dupixent (dupilumab) prescribing information, Warnings 5.2 conjunctivitis, keratitis and blepharitis · dailymed.nlm.nih.gov (opens in a new tab)
- European Medicines Agency · Dupixent: product information · www.ema.europa.eu (opens in a new tab)
- British Journal of Dermatology · An expert consensus on managing dupilumab-related ocular surface disorders in people with atopic dermatitis (2024) · pubmed.ncbi.nlm.nih.gov (opens in a new tab)
- Clinical & Experimental Allergy · Dupilumab-associated ocular surface disease in paediatric atopic dermatitis patients: results from the BioDay registry (2025) · pubmed.ncbi.nlm.nih.gov (opens in a new tab)
- Pediatric Dermatology · Dupilumab-associated ocular surface disease in pediatric atopic dermatitis: a single-centre Asian experience (2025) · pubmed.ncbi.nlm.nih.gov (opens in a new tab)
